NeuroPace (NPCE) Change in Account Payables (2020 - 2026)
NeuroPace (NPCE) posted Change in Account Payables of -$212000.0 for Q2 2026, down 109.66% on a QoQ basis from $2.2 million in Q1 2026, and down 128.77% year-over-year from $737000.0 in Q2 2025.
Powered by 
Analysis
NeuroPace (NPCE) Change in Account Payables (2020 - 2026) Analysis & Trends
NeuroPace has reported Change in Account Payables for 7 years, with the latest figure at -$212000.0 in Q2 2026.
- On a quarterly basis, Change in Account Payables fell 128.77% year-over-year to -$212000.0 in Q2 2026; TTM through Jun 2026 was -$450000.0, a 119.18% decrease from a year earlier, with the FY2025 full-year figure at -$730000.0, down 208.79% from the prior year.
- Change in Account Payables was -$212000.0 for Q2 2026 at NeuroPace, down from $2.2 million in the prior quarter.
- The five-year high for Change in Account Payables was $2.2 million in Q1 2026, with the low at -$2.4 million in Q4 2025.
- Average Change in Account Payables over 5 years is $156166.7, with a median of -$35000.0 recorded in 2023.
- The largest YoY upside for Change in Account Payables was 592.23% in 2024 against a maximum downside of 4090.91% in 2024.
- Over 5 years, Change in Account Payables stood at $855000.0 in 2022, then grew by 23.39% to $1.1 million in 2023, then decreased by 26.73% to $773000.0 in 2024, then plunged by 408.54% to -$2.4 million in 2025, then jumped by 91.11% to -$212000.0 in 2026.
- The last three Change in Account Payables figures came in at -$212000.0 (Q2 2026), $2.2 million (Q1 2026), and -$2.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 71.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 4.30 Mn |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn | -212,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -212,000.00 |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | -2.39 Mn |
| Sep 30, 2025 | -48,000.00 |
| Jun 30, 2025 | 737,000.00 |
| Mar 31, 2025 | 966,000.00 |
| Dec 31, 2024 | 773,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Jun 30, 2024 | -922,000.00 |
| Mar 31, 2024 | 950,000.00 |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | -600,000.00 |
| Jun 30, 2023 | -22,000.00 |
| Mar 31, 2023 | -193,000.00 |
| Dec 31, 2022 | 855,000.00 |
| Sep 30, 2022 | -301,000.00 |
| Jun 30, 2022 | -727,000.00 |
| Mar 31, 2022 | 820,000.00 |
| Dec 31, 2021 | 220,000.00 |
| Sep 30, 2021 | 191,000.00 |